Patent Yard Sign in
Expired Canadian patentCanada

Methods for separating malignant cells from clinical specimens

CA 1293216 C · Owner: Rotman, M. Boris · Inventors: Rotman, M. Boris

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Fragments of a biopsy sample on the order of about 50 to 5000 cells are preferred for establishing viable tumor cell cultures for purposes such as establishing cell lines, chemotherapeutic assays and the like. Such fragments retain the, three-dimensional cellular structure or organization of the original tumor and, therefore, can be cultured more readily. To obtain such fragments suitable for culturing, the biopsy sample can be enzymatically digested in a proteolytic or nucleolytic enzyme such, as collagenase, or by mechanical dissociation or, both where necessary. The fragments can then be suspended in an aqueous medium so that non-aggregated cells (e.g. red blood cells, lymphocytes …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted December 17, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 17, 2008.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 19, 1988
GrantedDecember 17, 1991
Term endedDecember 17, 2008
Patent numberCA 1293216 C
Classification (IPC)C12Q1/02 +2 more

Timeline

Timeline From CIPO dates

1989199119931995199719992001200320052007Application filedJan 19, 1988Patent grantedDec 17, 1991Term endedDec 17, 2008

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.